Several studies have defined the targets of miR-138 such as VIM, RhoC, Hif-1α, CCND1 and Sirt1 [31–33] in cancer types other than RCC, which are often involved in cell migration, EMT, DNA damage repair, senescence. This evidence concerns the gene RHOC and renal cell carcinoma.